New York-based investment firm I Squared Capital has pressed the start button on the long-awaited multibillion euro sale of ...

Viridian Therapeutics stock popped Monday after ... This beat out the 8% response rate in the placebo group and was in line with expectations for a 52% to 62% response rate, RBC Capital Markets ...

AlphaQuest LLC increased its stake in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 119.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 2,795 shares of ...

WALTHAM, Mass., March 10, 2025--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and ...